Brain+ ApS (BRAINP) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.964x

Based on the latest financial reports, Brain+ ApS (BRAINP) has a cash flow conversion efficiency ratio of -0.964x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-13.93 Million ≈ $-2.18 Million USD) by net assets (Dkr14.45 Million ≈ $2.26 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Brain+ ApS to measure how much of total assets are equity-financed.

Brain+ ApS - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Brain+ ApS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow reinvestment rate of Brain+ ApS to assess the company's total reinvestment commitment from operating cash flow.

Brain+ ApS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Brain+ ApS ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
REVITALIST L.A.W. LTD
F:4DO
N/A
National World PLC
LSE:NWOR
0.024x
Norrland Gold Corp
V:NORR
-0.074x
Frenkel Topping Group
LSE:FEN
0.040x
Vivanco Gruppe AG
F:VG0K
0.164x
Tower Investments SA
WAR:TOW
-0.116x
ALGERNON PHARMACEUT. A
F:AGW0
N/A
Kodal Minerals PLC
LSE:KOD
0.000x

Annual Cash Flow Conversion Efficiency for Brain+ ApS (2017–2024)

The table below shows the annual cash flow conversion efficiency of Brain+ ApS from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see BRAINP company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Dkr10.98 Million
≈ $1.72 Million
Dkr-9.25 Million
≈ $-1.45 Million
-0.842x +23.90%
2023-12-31 Dkr12.38 Million
≈ $1.94 Million
Dkr-13.71 Million
≈ $-2.14 Million
-1.107x -350.45%
2022-12-31 Dkr16.38 Million
≈ $2.56 Million
Dkr-4.03 Million
≈ $-629.80K
-0.246x +39.61%
2021-12-31 Dkr20.60 Million
≈ $3.22 Million
Dkr-8.38 Million
≈ $-1.31 Million
-0.407x -110.70%
2020-12-31 Dkr1.92 Million
≈ $300.09K
Dkr7.29 Million
≈ $1.14 Million
3.801x +74401.98%
2019-12-31 Dkr3.20 Million
≈ $500.19K
Dkr16.31K
≈ $2.55K
0.005x -99.56%
2018-12-31 Dkr6.24 Million
≈ $975.54K
Dkr7.29 Million
≈ $1.14 Million
1.169x +7.41%
2017-12-31 Dkr6.70 Million
≈ $1.05 Million
Dkr7.29 Million
≈ $1.14 Million
1.089x --

About Brain+ ApS

CO:BRAINP Denmark Health Information Services
Market Cap
$744.48K
Dkr4.76 Million DKK
Market Cap Rank
#30726 Global
#145 in Denmark
Share Price
Dkr0.00
Change (1 day)
+0.00%
52-Week Range
Dkr0.00 - Dkr0.02
All Time High
Dkr4.87
About

Brain+ A/S, a healthtech company, develops and commercializes technology solutions in dementia care primarily for cognitive stimulation therapy. The company is developing Ayla, a scalable dementia care platform that offers practical, human-centered, and clinically proven software-based dementia therapy and care solutions. It is also developing Ayla " your CST Assistant, a software-based dementia … Read more